Preeclampsia Ratio (sFlt-1/PlGF)

计划入组 84 人 · 首次发布于 2017 年 9 月 21 日

sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia

计划入组 87 人 · 首次发布于 2018 年 2 月 22 日

Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

计划入组 190 人 · 首次发布于 2024 年 5 月 8 日

AAV2sFLT01 (Applied Genetic Technologies/Genzyme)

1-naphthaleneacetic acid

C₁₂H₁₀O₂

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Novel sFlt-1 and Paclitaxel Combination Therapy Shows Synergistic Anti-Tumor Effects in 3D Breast Cancer Models

Blood Filtering Treatment Shows Promise for Severe Early Preeclampsia in Small Clinical Trial

Trinity Biotech Launches FDA-Cleared Preeclampsia Testing Service with Potential $10 Million Cost Savings